Metabolic acidosis with topiramate and zonisamide: An assessment of its severity and predictors

Pharmacogenetics and Genomics

Volumn 21, Issue 5, 2011, Pages 297-302

  Mirza, Nasir S ^a   Alfirevic, Ana ^a   Jorgensen, Andrea ^a   Marson, Anthony G ^a   Pirmohamed, Munir ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

acid base balance; carbonic anhydrase; epilepsy; renal tubular acidosis; topiramate; zonisamide

Indexed keywords

BICARBONATE; CARBONATE DEHYDRATASE II; CARBONATE DEHYDRATASE IV; CARBONATE DEHYDRATASE XII; ELECTROLYTE; TOPIRAMATE; ZONISAMIDE;

ADULT; AGED; ARTICLE; BICARBONATE BLOOD LEVEL; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC ACIDOSIS; PREVALENCE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT DURATION;

EID: 79955480833     PISSN: 17446872     EISSN: 17446880     Source Type: Journal    
DOI: 10.1097/FPC.0b013e3283441b95     Document Type: Article

References (34)

1. Winum JY, Poulsen SA, Supuran CT. Therapeutic applications of glycosidic carbonic anhydrase inhibitors. Med Res Rev 2009; 29:419-435.
2. Inoue T, Kira R, Kaku Y, Ikeda K, Gondo K, Hara T. Renal tubular acidosis associated with zonisamide therapy. Epilepsia 2000; 41:1642-1644. (Pubitemid 32002740)
3. Philippi H, Boor R, Reitter B. Topiramate and metabolic acidosis in infants and toddlers. Epilepsia 2002; 43:744-747. (Pubitemid 34774257)
4. Ozer Y, Altunkaya H. Topiramate induced metabolic acidosis. Anaesthesia 2004; 59:830.
5. Burmeister JE, Pereira RR, Hartke EM, Kreuz M. Topiramate and severe metabolic acidosis: case report. Arq Neuropsiquiatr 2005; 63:532-534. (Pubitemid 40942392)
6. Garris SS, Oles KS. Impact of topiramate on serum bicarbonate concentrations in adults. Ann Pharmacother 2005; 39:424-426. (Pubitemid 40270908)
7. Galla JH, Kurtz I, Kraut JA, Lipschik GY, Macrae JP. Acid-base disorders. In: Lerma EV, Berns JS, Nissenson AR, editors. Current diagnosis and treatment: nephrology and hypertension. USA: McGraw-Hill; 2009. pp. 45-54.
8. Sacre A, Jouret F, Manicourt D, Devuyst O. Topiramate induces type 3 renal tubular acidosis by inhibiting renal carbonic anhydrase. Nephrol Dial Transplant 2006; 21:2995-2996. (Pubitemid 44542275)
9. Stowe CD, Bollinger T, James LP, Haley TM, Griebel ML, Farrar HC III. Acute mental status changes and hyperchloremic metabolic acidosis with long-term topiramate therapy. Pharmacotherapy 2000; 20:105-109. (Pubitemid 30036111)
10. Tartara A, Sartori I, Manni R, Galimberti CA, Di Fazio M, Perucca E. Efficacy and safety of topiramate in refractory epilepsy: a long-term prospective trial. Ital J Neurol Sci 1996; 17:429-432. (Pubitemid 27019015)
11. Emmett M. Metabolic acidosis: general considerations. In: Gennari FJ, Adrogue HJ, Galla JH, Maddias N, editors. Acid-Base disorders and their treatment. Boca Raton: Taylor and Francis; 2005. pp. 293-313.
12. Shiber JR. Severe non-anion gap metabolic acidosis induced by topiramate: a case report. J Emerg Med 2010; 38:494-496.
13. Lynch MJ, Pizon AF, Siam MG, Krasowski MD. Clinical effects and toxicokinetic evaluation following massive topiramate ingestion. J Med Toxicol 2010; 6:135-138.
14. Langman LJ, Kaliciak HA, Boone SA. Fatal acute topiramate toxicity. J Anal Toxicol 2003; 27:323-324. (Pubitemid 36877178)
15. Alpern RJ, Sakhaee K. The clinical spectrum of chronic metabolic acidosis: homeostatic mechanisms produce significant morbidity. Am J Kidney Dis 1997; 29:291-302. (Pubitemid 27130744)
16. Purkerson JM, Schwartz GJ. The role of carbonic anhydrases in renal physiology. Kidney Int 2007; 71:103-115. (Pubitemid 46094683)
17. Liamis G, Milionis HJ, Elisaf M. Pharmacologically induced metabolic acidosis: a review. Drug Saf 2010; 33:371-391.
18. Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I. Controlling the false discovery rate in behavior genetics research. Behav Brain Res 2001; 125:279-284. (Pubitemid 33000466)
19. Lee PH, Shatkay H. F-SNP: computationally predicted functional SNPs for disease association studies. Nucleic Acids Res 2008; 36:D820-D824. (Pubitemid 351149829)
20. Lim BL, Kelly AM. A meta-analysis on the utility of peripheral venous blood gas analyses in exacerbations of chronic obstructive pulmonary disease in the emergency department. Eur J Emerg Med 2010; 17: 246-248.
21. Izzedine H, Launay-Vacher V, Deray G. Topiramate-induced renal tubular acidosis. Am J Med 2004; 116:281-282.
22. De Simone G, Scozzafava A, Supuran CT. Which carbonic anhydrases are targeted by the antiepileptic sulfonamides and sulfamates? Chem Biol Drug Des 2009; 74:317-321.
23. Belotti EA, Taddeo I, Ragazzi M, Pifferini R, Simonetti GD, Bianchetti MG, et al. Chronic impact of topiramate on acid-base balance and potassium in childhood. Eur J Paediatr Neurol 2010; 14:445-448.
24. Ramadan NM, Buchanan TM. New and future migraine therapy. Pharmacol Ther 2006; 112:199-212. (Pubitemid 44301490)
25. Vasudev K, Macritchie K, Geddes J, Watson S, Young AH. Topiramate for acute affective episodes in bipolar disorder. Cochrane Database Syst Rev 2006:CD003384.
26. Berlin HA. Antiepileptic drugs for the treatment of post-traumatic stress disorder. Curr Psychiatry Rep 2007; 9:291-300. (Pubitemid 47490000)
27. Supuran CT, Di Fiore A, De Simone G. Carbonic anhydrase inhibitors as emerging drugs for the treatment of obesity. Expert Opin Emerg Drugs 2008; 13:383-392. (Pubitemid 351957352)
28. Baltieri DA, Daro FR, Ribeiro PL, De Andrade AG. Comparing topiramate with naltrexone in the treatment of alcohol dependence. Addiction 2008; 103:2035-2044.
29. McElroy SL, Guerdjikova AI, Martens B, Keck PE Jr, Pope HG, Hudson JI. Role of antiepileptic drugs in the management of eating disorders. CNS Drugs 2009; 23:139-156.
30. Hollander E, Dell'Osso B. Topiramate plus paroxetine in treatmentresistant obsessive-compulsive disorder. Int Clin Psychopharmacol 2006; 21:189-191. (Pubitemid 43740312)
31. Celebisoy N, Gokcay F, Sirin H, Akyurekli O. Treatment of idiopathic intracranial hypertension: topiramate vs. acetazolamide, an open-label study. Acta Neurol Scand 2007; 116:322-327. (Pubitemid 47537419)
32. Bendaly EA, Jordan CA, Staehler SS, Rushing DA. Topiramate in the treatment of neuropathic pain in patients with cancer. Support Cancer Ther 2007; 4:241-246. (Pubitemid 47606351)
33. Zou LP, Lin Q, Qin J, Cai FC, Liu ZS, Mix E. Evaluation of open-label topiramate as primary or adjunctive therapy in infantile spasms. Clin Neuropharmacol 2008; 31:86-92. (Pubitemid 351489334)
34. Garcia Campayo J, Sobradiel N, Alda M, Mas A, Andres E, Magallon R, et al. Effectiveness of topiramate for tobacco dependence in patients with depression: a randomised, controlled trial. BMC Fam Pract 2008; 9:28.